GO:0120250 fatty acid omega-hydroxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120250 (fatty acid omega-hydroxylase activity) catalyzes the terminal (omega) hydroxylation of fatty acids using O2 and NADPH-derived reducing equivalents.
• The reaction converts an omega-methyl fatty acid to an omega-hydroxy fatty acid, producing H+, H2O, and oxidized NADPH--hemoprotein reductase.
• Most enzymes annotated with this activity belong to the cytochrome P450 CYP4 family, including CYP4A, CYP4F, and CYP4V subfamilies.
• CYP4A omega-hydroxylases generate 20-HETE from arachidonic acid, a lipid mediator implicated in hypertension and vascular tone.
• Dysregulated CYP4/omega-hydroxylase expression is linked to metabolic dysfunction-associated steatotic liver disease (MASLD) and other metabolic disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of CYP4 gene function in vitro and in vivo.
Description
Fatty acid omega-hydroxylase activity (GO:0120250) is a molecular function that introduces a hydroxyl group at the terminal (omega) carbon of a fatty acid chain. This reaction is catalyzed primarily by cytochrome P450 enzymes of the CYP4 family and requires molecular oxygen and reducing equivalents supplied by NADPH--hemoprotein reductase. The resulting omega-hydroxy fatty acids serve as precursors for further oxidation, as signaling lipids, and as intermediates in the generation of dicarboxylic acids. Because omega-hydroxylation alters the physicochemical properties and biological activity of fatty acids, it sits at the interface of lipid metabolism, eicosanoid signaling, and drug metabolism. Researchers study this activity to understand how cells handle excess fatty acids, how lipid mediators such as 20-hydroxyeicosatetraenoic acid (20-HETE) are produced, and how these pathways contribute to metabolic, cardiovascular, and renal physiology. The QuickGO definition specifies the balanced reaction: an omega-methyl fatty acid + O2 + reduced [NADPH--hemoprotein reductase] = an omega-hydroxy fatty acid + H+ + H2O + oxidized [NADPH--hemoprotein reductase]. This definition places the activity within the broader class of monooxygenase reactions that activate molecular oxygen and insert one oxygen atom into an organic substrate. In practical terms, assays for GO:0120250 measure the conversion of a fatty acid substrate to its omega-hydroxy product, often using HPLC, LC-MS, or radiometric detection. The term is therefore central to studies of fatty acid catabolism, bioactive lipid synthesis, and the pharmacology of CYP4 enzymes.
fatty acid omega-hydroxylase activity At A Glance
| GO ID | GO:0120250 |
|---|---|
| GO term | fatty acid omega-hydroxylase activity |
| Ontology | molecular_function |
| Synonym | omega-hydroxylase activity |
| Definition | Catalysis of the reaction: an omega-methyl fatty acid + O2 + reduced [NADPH--hemoprotein reductase] = an omega-hydroxy fatty acid + H+ + H2O + oxidized [NADPH--hemoprotein reductase] |
| Major function | Terminal hydroxylation of fatty acids to produce omega-hydroxy fatty acids and related lipid mediators |
| Representative enzymes | Cytochrome P450 CYP4 family members (e.g., CYP4A, CYP4F, CYP4V) |
| Cofactors | O2 and reduced NADPH--hemoprotein reductase |
| Substrate examples | Medium- and long-chain fatty acids, arachidonic acid, and omega-methyl fatty acids |
| Product examples | omega-hydroxy fatty acids and 20-HETE from arachidonic acid |
What Is GO:0120250?
In our own words, fatty acid omega-hydroxylase activity (GO:0120250) is the catalytic capacity to add a hydroxyl group to the terminal methyl carbon of a fatty acid, using molecular oxygen and electrons donated through a NADPH--hemoprotein reductase system. The reaction consumes O2 and reduced reductase, and releases the omega-hydroxy fatty acid, a proton, water, and oxidized reductase. This activity is distinct from other fatty acid hydroxylations because it targets the omega position rather than internal carbons or the carboxyl end.
Why Is fatty acid omega-hydroxylase activity Important in Cell Biology?
Fatty acid omega-hydroxylase activity is important because it controls the production of omega-hydroxy fatty acids and related eicosanoids that influence vascular tone, renal function, and lipid homeostasis. CYP4 enzymes that carry this activity are drug targets and are implicated in metabolic diseases such as MASLD, making the activity a focal point for both basic lipid biology and therapeutic development.
• Generates 20-HETE, a potent vasoactive eicosanoid involved in blood pressure regulation.
• Contributes to fatty acid catabolism and the formation of dicarboxylic acids.
• Modulates renal and cardiovascular physiology through CYP4A and CYP4F enzymes.
• Is dysregulated in metabolic dysfunction-associated steatotic liver disease (MASLD).
• Represents a druggable node for modulating 20-HETE synthase and fatty acid omega-hydroxylase activities.
• Provides a biochemical route to omega-hydroxy fatty acids used in signaling and industrial applications.
• Serves as a model for P450 monooxygenase chemistry and substrate promiscuity.
• Links lipid metabolism to inflammation and oxidative stress pathways.
Molecular Mechanism of fatty acid omega-hydroxylase activity
Substrate binding and orientation
In simple terms: The enzyme grabs a fatty acid and positions its tail end for modification.
CYP4 enzymes bind fatty acid substrates within a hydrophobic active site that positions the terminal methyl group near the heme iron. The orientation ensures that hydroxylation occurs at the omega carbon rather than at internal positions. Substrate specificity varies among CYP4A, CYP4F, and CYP4V enzymes, allowing different chain lengths and unsaturation patterns to be accommodated.
Oxygen activation and heme chemistry
In simple terms: The enzyme uses oxygen and electrons to create a reactive species that inserts an oxygen atom into the fatty acid.
The catalytic cycle begins with substrate binding to the ferric heme, followed by reduction and binding of O2 to form a ferrous-dioxygen complex. A second reduction and protonation steps lead to cleavage of the O--O bond, generating a reactive iron-oxo species that abstracts a hydrogen atom from the omega methyl group. Rebound of the hydroxyl radical to the substrate carbon yields the omega-hydroxy product.
Electron transfer from NADPH--hemoprotein reductase
In simple terms: A partner protein supplies the electrons needed to power the reaction.
NADPH--hemoprotein reductase (also known as cytochrome P450 reductase) transfers electrons from NADPH to the CYP4 heme center. This electron transfer is essential for oxygen activation and for completing the catalytic cycle. The reaction stoichiometry includes oxidation of the reductase, which is regenerated by NADPH.
Product formation and release
In simple terms: The modified fatty acid is released, and the enzyme resets for another round.
After hydroxyl rebound, the omega-hydroxy fatty acid dissociates from the active site, accompanied by release of water and a proton. The enzyme returns to its resting ferric state, ready for another catalytic cycle. The product can undergo further oxidation to a carboxylic acid or serve as a signaling molecule.
Regulation of enzyme levels and activity
In simple terms: Cells adjust how much of the enzyme is made and how active it is.
CYP4 gene expression is regulated by nuclear receptors such as PPAR-alpha and by nutritional and hormonal signals. Enzyme activity can also be modulated by inhibitors and inducers, including fatty acids and xenobiotics. In disease states such as MASLD, altered CYP4 expression patterns correlate with changes in omega-hydroxylase activity.
Key Genes Involved in GO:0120250 fatty acid omega-hydroxylase activity
The following genes encode enzymes or associated proteins that carry or support fatty acid omega-hydroxylase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP4A11 | Omega-hydroxylase that converts arachidonic acid to 20-HETE | Hypertension and renal function studies |
| CYP4A22 | Fatty acid omega-hydroxylase in humans | Metabolic and cardiovascular research |
| CYP4A7 | Rabbit kidney fatty acid omega-hydroxylase | Enzyme kinetics and substrate specificity |
| CYP4F2 | Omega-hydroxylase for leukotrienes and fatty acids | Inflammation and drug metabolism |
| CYP4F3 | Omega-hydroxylase for leukotriene B4 | Inflammatory mediator clearance |
| CYP4V2 | Omega-hydroxylase involved in lipid metabolism | Retinal and metabolic disease models |
| CYP4B1 | Fatty acid omega-hydroxylase | Xenobiotic and lipid metabolism |
| CYP4X1 | Brain-enriched omega-hydroxylase | Neurovascular and lipid signaling |
| CYP4Z1 | Omega-hydroxylase with tumor-associated expression | Cancer biology and biomarker studies |
| CYP4A1 | Rodent omega-hydroxylase | Model organism studies of 20-HETE |
| CYP4A2 | Rodent omega-hydroxylase | Renal and hepatic lipid metabolism |
| CYP4A3 | Rodent omega-hydroxylase | Peroxisome proliferator responses |
| CYP4F1 | Rodent omega-hydroxylase | Inflammation and lipid mediator studies |
| CYP4F4 | Omega-hydroxylase for eicosanoids | Vascular biology |
| CYP4F5 | Omega-hydroxylase for fatty acids | Lipid signaling research |
| CYP4F6 | Omega-hydroxylase for leukotrienes | Inflammatory pathways |
| CYP4A90 | Plant fatty acid omega-hydroxylase | Biosynthesis of floral nitro compounds |
How Is fatty acid omega-hydroxylase activity Regulated?
Fatty acid omega-hydroxylase activity is regulated at multiple levels. Transcriptional control of CYP4 genes involves nuclear receptors such as PPAR-alpha, which responds to fatty acids and fibrates. Enzyme activity can be inhibited or induced by pharmacological agents, including ABT and other P450 inhibitors. In disease contexts such as MASLD, expression changes in CYP4 family genes correlate with altered omega-hydroxylase activity, suggesting feedback regulation by lipid load and inflammatory signals. Post-translational mechanisms and substrate availability further modulate flux through this pathway.
fatty acid omega-hydroxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP4A11 | Hypertension and 20-HETE production | CYP4A11 knockout or overexpression in vascular smooth muscle cells |
| CYP4F2 | Inflammation and leukotriene metabolism | CYP4F2 point-mutation knock-in in macrophages |
| CYP4V2 | Metabolic and retinal lipid disorders | CYP4V2 knockout in hepatocytes or retinal cells |
| CYP4A1 | Renal function and blood pressure | CYP4A1 knockout rat models |
| CYP4A90 | Plant floral nitro compound biosynthesis | CYP4A90 overexpression in plant cells |
Hypertension and cardiovascular disease
CYP4A omega-hydroxylases produce 20-HETE, a vasoconstrictor eicosanoid that contributes to hypertension. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in spontaneously hypertensive rats, demonstrating a causal link between this activity and blood pressure regulation. The CYP/20-HETE/GPR75 axis has emerged as a therapeutic target in hypertension.
Metabolic dysfunction-associated steatotic liver disease (MASLD)
RNA sequence database analysis and review indicate that CYP4 family fatty acid omega hydroxylase genes are differentially expressed in MASLD progression. These changes may reflect adaptive or maladaptive responses to lipid accumulation and inflammation in the liver. Targeting omega-hydroxylase activity is being explored for metabolic liver disease.
Renal and vascular function
Omega-hydroxylase activity in the kidney regulates sodium transport and vascular tone through 20-HETE production. Dysregulation of this pathway is implicated in renal injury and hypertension. CYP4 enzymes are therefore studied as modulators of renal physiology.
Inflammation and eicosanoid signaling
CYP4F enzymes omega-hydroxylate leukotrienes and other eicosanoids, influencing inflammatory resolution. This activity links fatty acid omega-hydroxylation to inflammatory pathways and immune cell function. Pharmacological modulation of these enzymes is a potential anti-inflammatory strategy.
From fatty acid omega-hydroxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP4A11 reduce 20-HETE production? | CYP4A11 knockout cell line |
| Does a specific CYP4F2 variant alter omega-hydroxylase activity? | CYP4F2 point-mutation knock-in |
| Can tagged CYP4A7 be used to track subcellular localization? | CYP4A7 tagged knock-in |
| Does CYP4V2 overexpression increase omega-hydroxy fatty acid levels? | CYP4V2 overexpression cell model |
| Which CYP4 genes are essential for MASLD progression? | CRISPR library screening in hepatocyte models |
| Does CYP4A90 expression alter floral volatile production? | CYP4A90 overexpression in plant cells |
How to Study the fatty acid omega-hydroxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS lipidomics | Omega-hydroxy fatty acid and 20-HETE levels | Quantifying pathway flux in cells and tissues |
| HPLC-based enzyme assay | Conversion of fatty acid substrate to omega-hydroxy product | In vitro enzyme kinetics |
| RNA-seq | CYP4 gene expression levels | Transcriptional profiling in disease models |
| qPCR | Relative mRNA abundance of CYP4 genes | Validation of expression changes |
| CRISPR knockout | Loss-of-function effects on omega-hydroxylase activity | Causal gene function studies |
| Overexpression | Gain-of-function effects on product formation | Enzyme capacity and pathway flux |
| Immunoblotting | Protein expression of CYP4 enzymes | Correlating protein levels with activity |
| Radiometric assay | Radioactive product formation from labeled substrate | Sensitive detection of enzyme activity |
Enzyme activity assays
Omega-hydroxylase activity is measured by incubating cell or tissue lysates with fatty acid substrates and NADPH, followed by detection of omega-hydroxy products using HPLC, LC-MS, or radiometric methods. These assays provide direct biochemical evidence of GO:0120250 activity.
Gene expression analysis
RNA-seq and qPCR are used to quantify CYP4 gene expression in cells and tissues, revealing transcriptional regulation of omega-hydroxylase enzymes. Database analyses of RNA-seq datasets have identified CYP4 expression changes in MASLD.
Lipidomics and metabolomics
LC-MS-based lipidomics measures omega-hydroxy fatty acids and 20-HETE levels, providing a readout of pathway flux. Metabolomic profiling can link omega-hydroxylase activity to broader lipid metabolic networks.
Genetic and pharmacological perturbation
CRISPR knockout, overexpression, and small-molecule inhibitors are used to perturb CYP4 genes and assess effects on omega-hydroxylase activity and downstream phenotypes. These approaches establish causal roles for specific enzymes.
How CRISPR Can Be Used to Study GO:0120250 fatty acid omega-hydroxylase activity
Knockout
CRISPR knockout of CYP4 genes eliminates omega-hydroxylase activity for specific substrates, allowing researchers to attribute product formation to individual enzymes. For example, CYP4A11 knockout cells show reduced 20-HETE production, confirming its role in arachidonic acid omega-hydroxylation.
Point Mutation
Point mutations can be introduced into CYP4 genes to test the impact of specific amino acid variants on catalytic activity and substrate specificity. This approach helps distinguish loss-of-function from gain-of-function alleles in disease-associated variants.
Knock-in
Knock-in of tagged or reporter-tagged CYP4 alleles enables tracking of enzyme localization and dynamics in live cells. Tagged knock-in models also facilitate affinity purification and interaction studies.
Overexpression
Overexpression of CYP4 genes in cell lines increases omega-hydroxylase capacity and product formation, useful for biochemical characterization and pathway flux studies. Plant CYP4A90 overexpression, for example, has been used to study floral nitro compound biosynthesis.
How EDITGENE Supports fatty acid omega-hydroxylase activity Research
Researchers studying fatty acid omega-hydroxylase activity-related genes often need to determine whether a candidate CYP4 gene is causally involved in a specific metabolic or cardiovascular phenotype. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of these genes in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for fatty acid omega-hydroxylase activity research.
Frequently Asked Questions About fatty acid omega-hydroxylase activity
What is fatty acid omega-hydroxylase activity?
It is the enzymatic activity (GO:0120250) that adds a hydroxyl group to the terminal carbon of a fatty acid using oxygen and NADPH-derived electrons.
What genes are involved in fatty acid omega-hydroxylase activity?
The main genes are cytochrome P450 CYP4 family members, including CYP4A, CYP4F, and CYP4V subfamilies.
What is the reaction catalyzed by GO:0120250?
An omega-methyl fatty acid + O2 + reduced NADPH--hemoprotein reductase yields an omega-hydroxy fatty acid + H+ + H2O + oxidized reductase.
Which enzymes carry fatty acid omega-hydroxylase activity?
CYP4A, CYP4F, CYP4V, and related P450 enzymes are the principal carriers of this activity.
How is fatty acid omega-hydroxylase activity measured?
It is measured by incubating substrates with enzyme sources and detecting omega-hydroxy products via HPLC, LC-MS, or radiometric assays.
What diseases are linked to fatty acid omega-hydroxylase activity?
Hypertension, cardiovascular disease, MASLD, and inflammatory conditions have been linked to altered CYP4/omega-hydroxylase function.
What is the role of 20-HETE in hypertension?
20-HETE is a vasoconstrictor produced by CYP4A omega-hydroxylases and contributes to blood pressure regulation.
Can CRISPR be used to study fatty acid omega-hydroxylase genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of CYP4 gene function.
What is the difference between omega-hydroxylase and other fatty acid hydroxylases?
Omega-hydroxylase targets the terminal methyl carbon, whereas other hydroxylases act on internal carbons or the carboxyl end.
Which model organisms are used to study fatty acid omega-hydroxylase activity?
Rats, rabbits, and cell lines are commonly used, with CYP4A1 and CYP4A7 as representative enzymes.
Conclusion
Fatty acid omega-hydroxylase activity (GO:0120250) is a key enzymatic function that converts fatty acids to omega-hydroxy products and bioactive lipids such as 20-HETE. Its dysregulation is implicated in hypertension, MASLD, and inflammatory diseases, making it a compelling target for both basic and translational research. CRISPR-based cell models provide powerful tools to dissect the roles of individual CYP4 genes and to identify new therapeutic opportunities.
References
- 1. Leahy C et al.. 2024. The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.. Biochem Pharmacol 228:116241 PMID: 38697309
- 2. Yamaguchi T et al.. 2021. A promiscuous fatty acid ω-hydroxylase CYP94A90 is likely to be involved in biosynthesis of a floral nitro compound in loquat (Eriobotrya japonica).. New Phytol 231(3):1157-1170 PMID: 33932032
- 3. Okita RT et al.. 2001. Cytochrome P450 4A fatty acid omega hydroxylases.. Curr Drug Metab 2(3):265-81 PMID: 11513330
- 4. Hardwick JP. 2008. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.. Biochem Pharmacol 75(12):2263-75 PMID: 18433732
- 5. Su P et al.. 1998. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.. Am J Physiol 275(2):R426-38 PMID: 9688677
- 6. Edson KZ et al.. 2013. CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities.. Curr Top Med Chem 13(12):1429-40 PMID: 23688133
- 7. Froogh G et al.. 2022. The CYP/20-HETE/GPR75 axis in hypertension.. Adv Pharmacol 94:1-25 PMID: 35659370
- 8. Sawamura A et al.. 1993. Catalytic properties of rabbit kidney fatty acid omega-hydroxylase cytochrome P-450ka2 (CYP4A7).. Biochim Biophys Acta 1168(1):30-6 PMID: 8504139
